Scholar IQ
Help
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

PaperCitations, authors & open-access status
3,352
Citations
2,019
Year
green
OA Status
Related on ScholarIQ
Gregory M. Lubiniecki
Author
Libor Havel
Author
Flávia De Angelis
Author
Myung‐Ju Ahn
Author
Gilberto de Castro
Author
The Lancet
Journal
470M+ articles · free account